Skip to content

CytoSorb therapy in ECMO patients – an update

Chair: Prof. Manu Malbrain, Brussels/Belgium and Prof. Ralf Muellenbach, Kassel/Germany

  • Overwhelming inflammation in ECMO – when and how to face it?
    Prof. Leonardo Gottin, Verona/Italy
  • Early use of cytokine adsorption in severe COVID-19 pneumonia requiring VV-ECMO – first results from the CYCOV trial
    Dr. Alexander Supady, Freiburg/Germany
  • Can VV-ECMO patients with severe pneumogenic sepsis benefit from CytoSorb therapy? Results from a retrospective study
    Dr. Ali Akil, Ibbenbueren/Germany
Play Video

Share

|

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

CytoSorb therapy in ECMO patients – an update

Play Video

Share

|

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Chair: Prof. Manu Malbrain, Brussels/Belgium and Prof. Ralf Muellenbach, Kassel/Germany

  • Overwhelming inflammation in ECMO – when and how to face it?
    Prof. Leonardo Gottin, Verona/Italy
  • Early use of cytokine adsorption in severe COVID-19 pneumonia requiring VV-ECMO – first results from the CYCOV trial
    Dr. Alexander Supady, Freiburg/Germany
  • Can VV-ECMO patients with severe pneumogenic sepsis benefit from CytoSorb therapy? Results from a retrospective study
    Dr. Ali Akil, Ibbenbueren/Germany

More Videos

Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | CytoSorb therapy in COVID-19 patients
Webinar | CytoSorb therapy in COVID-19 patients